Logo

Expression Pathology Closes $300,000 Funding Round

May 03, 2004

NEW YORK, May 3 (GenomeWeb News) - Gaithersburg, Md.-based start-up Expression Pathology announced today that it has closed a $300,000 funding round.

 

The funds came from: early stage angel investors, the Maryland Department of Business and Economic Development, and a Maryland Technology Transfer Fund from the Maryland Technology Development Corporation.

 

Expression Pathology is developing Liquid Tissue protein arrays from archived tissue banks using laser microdissection techniques and a process that converts tissue into a liquid format suitable for printing arrays, according to the company.

 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.